United States · FDA National Drug Code directory

Palonosetron Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
36000-326_4d54b4d2-3572-4693-bfe1-2550abc5f439
Product NDC
36000-326
Form
INJECTION
Composition / generic term
palonosetron hydrochloride
Labeler
Baxter Healthcare Corporation
Marketing category
ANDA
Marketing start / end (source format)
20211112
Source listing expiry
20261231

Source-listed ingredients

  • PALONOSETRON HYDROCHLORIDE — .25 mg/5mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL in 1 CARTON (36000-326-02) / 5 mL in 1 VIAL (36000-326-01) · 36000-326-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →